A real-time in vivo clearance assay for quantification of glymphatic efflux
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
A real-time in vivo clearance assay for quantification of glymphatic efflux. / Plá, Virginia; Bork, Peter; Harnpramukkul, Aurakoch; Olveda, Genaro; Ladrón-de-Guevara, Antonio; Giannetto, Michael J.; Hussain, Rashad; Wang, Wei; Kelley, Douglas H.; Hablitz, Lauren M.; Nedergaard, Maiken.
In: Cell Reports, Vol. 40, No. 11, 111320, 2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A real-time in vivo clearance assay for quantification of glymphatic efflux
AU - Plá, Virginia
AU - Bork, Peter
AU - Harnpramukkul, Aurakoch
AU - Olveda, Genaro
AU - Ladrón-de-Guevara, Antonio
AU - Giannetto, Michael J.
AU - Hussain, Rashad
AU - Wang, Wei
AU - Kelley, Douglas H.
AU - Hablitz, Lauren M.
AU - Nedergaard, Maiken
N1 - Publisher Copyright: © 2022
PY - 2022
Y1 - 2022
N2 - Glymphatic fluid transport eliminates metabolic waste from the brain including amyloid-β, yet the methodology for studying efflux remains rudimentary. Here, we develop a method to evaluate glymphatic real-time clearance. Efflux of Direct Blue 53 (DB53, also T-1824 or Evans Blue) injected into the striatum is quantified by imaging the DB53 signal in the vascular compartment, where it is retained due to its high affinity to albumin. The DB53 signal is detectable as early as 15 min after injection and the efflux kinetics are sharply reduced in mice lacking the water channel aquaporin 4 (AQP4). Pharmacokinetic modeling reveal that DB53 efflux is consistent with the existence of two efflux paths, one with fast kinetics (T1/2 = 50 min) and another with slow kinetics (T1/2 = 240 min), in wild-type mice. This in vivo methodology will aid in defining the physiological variables that drive efflux, as well as the impact of brain states or disorders on clearance kinetics.
AB - Glymphatic fluid transport eliminates metabolic waste from the brain including amyloid-β, yet the methodology for studying efflux remains rudimentary. Here, we develop a method to evaluate glymphatic real-time clearance. Efflux of Direct Blue 53 (DB53, also T-1824 or Evans Blue) injected into the striatum is quantified by imaging the DB53 signal in the vascular compartment, where it is retained due to its high affinity to albumin. The DB53 signal is detectable as early as 15 min after injection and the efflux kinetics are sharply reduced in mice lacking the water channel aquaporin 4 (AQP4). Pharmacokinetic modeling reveal that DB53 efflux is consistent with the existence of two efflux paths, one with fast kinetics (T1/2 = 50 min) and another with slow kinetics (T1/2 = 240 min), in wild-type mice. This in vivo methodology will aid in defining the physiological variables that drive efflux, as well as the impact of brain states or disorders on clearance kinetics.
KW - aquaporin 4
KW - brain clearance
KW - brain fluid transport
KW - cerebrospinal fluid
KW - CP: Neuroscience
KW - glymphatic system
KW - waste efflux
U2 - 10.1016/j.celrep.2022.111320
DO - 10.1016/j.celrep.2022.111320
M3 - Journal article
C2 - 36103828
AN - SCOPUS:85138108547
VL - 40
JO - Cell Reports
JF - Cell Reports
SN - 2211-1247
IS - 11
M1 - 111320
ER -
ID: 343131000